From what I've seen, the ability to predict a short squeeze in biotech runs at about 0.00001%. Certainly, my record is 0-1.
Nonetheless, due to the type of company that I seek out for a long position, I made gobs of profit from my lousy prediction.
Now? Biotech investors come in all types. Some are comfortable for life, trying to win a bit more for the grandkids, to cover that annual check to the alumni assn. or Amer. Cancer Society, etc. For those investors and ONLY those investors, it may be fun, every now and then, to bet against the really inept shorts who target the sector.
MYGN..... large short position, no rationale IMO. I believe that everyone who can afford to take a small position should do such. I'm long, holding a 50% position without the guts to go further. I believe that this side of the trade has, by far, the greatest leverage. Please form your own opinion. |
